HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: cashflow_investing
| Value | {"amount": -333000000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:22:41.541960+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/c402c9b4-fc2a-421f-a805-df6e05f55f42
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300BNS685UXH4JI75:2024-12-31Retrieved: 2026-08-23T23:22:41.541960+02:00
Raw response sha256:
fa360d060b2925ef088a58e6bc26f82a…Cite as: FACTANKER, https://factanker.com/fact/c402c9b4-fc2a-421f-a805-df6e05f55f42
History
- no predecessors — first report